Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. (Q37282330)
Jump to navigation
Jump to search
scientific article published on 15 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. |
scientific article published on 15 August 2013 |
Statements
1 reference
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age. (English)
1 reference
Carlos E Vigil
1 reference
Wei Tan
1 reference
George Deeb
1 reference
Sheila N Sait
1 reference
Annemarie W Block
1 reference
Petr Starostik
1 reference
Elizabeth A Griffiths
1 reference
James E Thompson
1 reference
Jessica D Greene
1 reference
Laurie A Ford
1 reference
Eunice S Wang
1 reference
Meir Wetzler
1 reference
1 reference
Identifiers
1 reference